These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 7807004

  • 1. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.
    Fikrig E, Telford SR, Wallich R, Chen M, Lobet Y, Matuschka FR, Kimsey RB, Kantor FS, Barthold SW, Spielman A, Flavell RA.
    J Exp Med; 1995 Jan 01; 181(1):215-21. PubMed ID: 7807004
    [Abstract] [Full Text] [Related]

  • 2. Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines.
    Telford SR, Fikrig E, Barthold SW, Brunet LR, Spielman A, Flavell RA.
    J Exp Med; 1993 Aug 01; 178(2):755-8. PubMed ID: 8340764
    [Abstract] [Full Text] [Related]

  • 3. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
    de Silva AM, Telford SR, Brunet LR, Barthold SW, Fikrig E.
    J Exp Med; 1996 Jan 01; 183(1):271-5. PubMed ID: 8551231
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi.
    Golde WT, Burkot TR, Piesman J, Dolan MC, Capiau C, Hauser P, Dequesne G, Lobet Y.
    Vaccine; 1995 Apr 01; 13(5):435-41. PubMed ID: 7639011
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi.
    Golde WT, Piesman J, Dolan MC, Kramer M, Hauser P, Lobet Y, Capiau C, Desmons P, Voet P, Dearwester D, Frantz JC.
    Infect Immun; 1997 Mar 01; 65(3):882-9. PubMed ID: 9038292
    [Abstract] [Full Text] [Related]

  • 12. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
    Luke CJ, Carner K, Liang X, Barbour AG.
    J Infect Dis; 1997 Jan 01; 175(1):91-7. PubMed ID: 8985201
    [Abstract] [Full Text] [Related]

  • 13. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites.
    Gern L, Rais O, Capiau C, Hauser P, Lobet Y, Simoen E, Voet P, Pêtre J.
    Immunol Lett; 1994 Mar 01; 39(3):249-58. PubMed ID: 8034340
    [Abstract] [Full Text] [Related]

  • 14. Vaccination against Lyme borreliosis.
    Wahlberg P.
    Ann Med; 1999 Aug 01; 31(4):233-5. PubMed ID: 10480752
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.
    Probert WS, LeFebvre RB.
    Infect Immun; 1994 May 01; 62(5):1920-6. PubMed ID: 8168958
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.